英国NHS每年将支付最高3,000英镑的GP, 开出减肥药品, England’s NHS will pay GPs up to £3,000 yearly to prescribe weight-loss drugs to expand access for patients with severe obesity.

作为增加获得治疗机会和缩小差距的2 500万英镑努力的一部分,英格兰国民保健制度每年向全科医生提供多达3 000英镑的药品,以便开具Mounjaro和Wegovy等减肥药品。 As part of a £25 million effort to increase access and lessen disparities, the NHS in England is providing general practitioners with up to £3,000 per year to prescribe weight-loss medications like Mounjaro and Wegovy. 除了支持将严重肥胖患者和相关健康状况列为优先事项的长期国民保健制度的推出外,这项举措还旨在增加这些药品的公平使用,这些药品目前大多是私人获取的。 In addition to supporting a long-term NHS rollout that prioritizes patients with severe obesity and related health conditions, the move aims to increase equitable use of these medications, which are currently mostly obtained privately. 卫生秘书Wes Streeting警告人们注意不受管制和私人使用的危险,并强调获得治疗应该由医疗需要而不是财政手段决定。 Wes Streeting, the health secretary, warned against the dangers of unregulated and private use and emphasized that access should be determined by medical necessity rather than financial means. 尽管采取了奖励措施,但预计头三年只有大约220 000名病人得到治疗,这引起了可持续性和工作量方面的问题。 Only roughly 220,000 patients are anticipated to receive treatment in the first three years, despite the incentives, raising questions about sustainability and workload.